Navigation Links
New drug for non-Hodgkin lymphoma and chronic lymphocytic leukemia passes early test
Date:5/23/2014

A new chemotherapy drug being investigated for its potency against two types of cancer was found by scientists at Houston Methodist and seven other institutions to be effective in about one-third of the 58 patients who participated in a phase I study.

The drug, alisertib or MLN8237, inhibits the enzyme aurora A kinase, which is known to be very active during cell division. The present study, published in the journal Investigational New Drugs, looks at the safety, tolerability, and preliminary success of alisertib in treating non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).

"An advantage with this drug is it is oral and very effective in a significant number of patients with aggressive lymphoma when used at that dose for 7 days out a 21 day cycle," said hematologist Swaminathan Iyer, M.D., who led the multi-site study.

Drugs commonly used to treat NHL and CLL are chemotherapeutic drugs and some biological targeted agents such as the monoclonal antibodies rituximab, ofatumumab and obinutuzumab with varying degrees of success.

Although about 1/2 of patients participating in the phase I study experienced side effects most of which were manageable events, Iyer said that is not unusual for such biologic (non chemotherapy) drugs.

"The side effects were fairly tolerable in this study," Iyer said. "We would like to see more information from a larger group of patients to fully understand the drug's safety and tolerability for those experiencing the middle-to-later stages of these diseases."

Iyer and his group recommend 50 mg, twice-daily doses of alisertib for the advanced phase trials of the drug, which Iyer says has begun enrollment.

Alisertib is not yet approved for general medical use by the FDA. Its impact on T cell lymphoma is being investigated in a separate, phase III trial for a specific type of lymphoma called the T cell lymphomas. Houston Methodist is a participating study
'/>"/>

Contact: David Bricker
dmbricker@houstonmethodist.org
832-667-5811
Houston Methodist
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Epigenomic abnormalities predict patient survival in non-Hodgkins lymphoma
2. Novel drug therapy targets aggressive form of non-Hodgkins lymphoma
3. International symposium will address non-Hodgkins lymphoma in the young
4. Inhibition of CDK4 might promote lymphoma development and progression
5. Increased risk of relapse omitting RT in early PET scan negative Hodgkin lymphoma
6. Chemo-free treatment a possibility for leukemia/lymphoma
7. Scientists explore promising new option for first line of attack in lymphoma
8. Breakthrough in treating leukemia, lymphoma with umbilical cord blood stem cells
9. MedMar Healing Center Co-founder Rafael Hernandez Goes the Distance for Leukemia and Lymphoma Society, Running Three Marathons for Nonprofit Health Organization
10. Research shows genetic anti-inflammatory defect predisposes children to lymphoma
11. Reprogrammed treatment-resistant lymphomas respond to cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... 02, 2015 It’s a pattern that ... disaster strikes anywhere on this planet, cyber scammers will ... and compassion for their own personal gain. And ... Readiness Team) issued an alert titled “Nepal Earthquake ... scams citing the earthquake in Nepal. The scam emails ...
(Date:5/2/2015)... 02, 2015 As a nonsurgical ... of the face, neck and décolleté, radiofrequency energy ... real potential for the success of vulvovaginal rejuvenation. ... Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory ... concluded that ThermiGyn’s temperature controlled radio frequency, specifically ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members ... federal support for telemedicine. , “Such action is ... with Congress,” said Jonathan Linkous, CEO of the American Telemedicine ... poised to embrace the use of telecommunications in the delivery ... ATA’s mission to improve quality, access, equity and affordability of ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up ... to help protect the rights of adolescent girls in India. ... added since Girl Up began almost five years ago – ... adolescent girls in the Rajasthan region of India. , ... advancement of adolescent girls in Guatemala, Ethiopia, Liberia, and Malawi. ...
Breaking Medicine News(10 mins):Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3
... homes, seniors increasingly turning to home care vs. assisted ... estate crisis has affected all aspects of life, and ... unable to sell their homes, moving to an assisted ... reason, the option of aging-in-place with retrofits is growing ...
... lead to blood clots, study says , , THURSDAY, Jan. ... don,t seem to increase the risk of heart disease as ... , But more research on the newer generations of contraceptives ... true because more women over age 35 are taking hormonal ...
... spending on health IT, Congress should first fix the ... control over their personal health information," says Sue A. ... "Right now, the HIPAA privacy rule has too ... Blevins stresses. , , IHF released ...
... cancer patient Debra Gardocki receives an injection from oncologist ... a new approach to treat advanced melanoma -- an ... limited effective treatment options. The study -- which is ... United States and Canada -- includes combining a therapeutic ...
... The $800 million settlement that Eli,Lilly and Company (NYSE: ... civil False Claims,Act charges related to allegedly false or fraudulent ... to the courageous stands taken by,employee whistleblowers, according to the ... The company,s settlement with the federal government, which also includes,a ...
... Awards ScholarshipWASHINGTON, Jan. 15 High ... chance to score some extra cash from got milk?(R) for ... with USA TODAY, has launched the 12th annual Scholar Athlete ... Awards reward 25 high school senior student athletes who demonstrate ...
Cached Medicine News:Health News:Housing Crisis Affects Seniors Needing Care 2Health News:Housing Crisis Affects Seniors Needing Care 3Health News:Newer Contraceptives Don't Increase Heart Risk 2Health News:Newer Contraceptives Don't Increase Heart Risk 3Health News:Economic Stimulus Package Could Impinge on Americans' Health Privacy 2Health News:A Shot in the Arm to Fight Skin Cancer 2Health News:Whistleblowers' Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy 2Health News:Video: Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 2Health News:Video: Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 3
(Date:5/1/2015)... -- Following yesterday,s release of Center for Medicaid and Medicare ... you need to know: ... government programs. , ... parts of Medicare and other government programs because it relies ... prescription drug benefits to enrollees. , Competition and rebates ...
(Date:5/1/2015)... PLEASANTON, Calif. , May 1, 2015  Thoratec Corporation ... support therapies to save, support and restore failing hearts, announced ... the newly created role of President, International. This ... all Thoratec commercial operations outside of North America ... Asia , and Latin America , ...
(Date:5/1/2015)... May 1, 2015  Legendary actor and director ... new PBAFacts campaign designed to educate and encourage patients ... about Pseudobulbar Affect (PBA) and to speak with their ... actor has the ability to cry and laugh on ... control experienced by people living with PBA episodes. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Nov. 15, 2010 Spherix Incorporated (Nasdaq: ... diabetes and the metabolic syndrome, and a provider of ... and pharmaceutical companies, today reported results for the three ... and Upcoming Highlights Pharmaceutical Development ...
... 15, 2010 /PRNewswire-- Sangart, Inc., a global ... designed to enhance the perfusion and oxygenation of ... other gas delivery, today announced that its investigational ... designation by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Spherix Announces Third Quarter 2010 Financial Results 2Spherix Announces Third Quarter 2010 Financial Results 3Spherix Announces Third Quarter 2010 Financial Results 4Spherix Announces Third Quarter 2010 Financial Results 5Spherix Announces Third Quarter 2010 Financial Results 6Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3
Combined Screen (RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) ELISA kit....
... Scientific, Inc. ENA Screen ELISA test system ... detect antibodies to extractable nuclear antigens (anti-ENA) ... the directional insert, this test system is ... for, such as those against Jo-1, Sm, ...
... Single Well Screening Kit is designed to screen ... autoantibodies. Each microtiter well is coated with Sm, ... allows the laboratory to cost effectively screen out ... the ENA specificity on any of the company's ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
Medicine Products: